요즈마 그룹 코리아요즈마 그룹 코리아
  • Korean
  • About
    • Chairman
    • Overview
    • People
      • Team
      • Advisors & Partners
  • Business
  • YIC
  • Portfolio
  • Newsroom
  • Contact
Press enter to begin your search
Todos Medical says dietary supplement Tollovid has beneficial effect in long COVID case study after 26 days

Todos Medical says dietary supplement Tollovid has beneficial effect in long COVID case study after 26 days

yozmakorea 2022-06-02 June 27th, 2022

Todos Medical says dietary supplement Tollovid has beneficial effect in long COVID case study after 26 days

https://www.proactiveinvestors.com/companies/news/983880/todos-medical-says-dietary-supplement-tollovid-has-beneficial-effect-in-long-covid-case-study-after-26-days-983880.html
News No Comments
Share Tweet Share Pin

Seoul Address
5F, SB Tower, 318 Dosan-daero, Gangnam-Gu, Seoul 06054, Republic of Korea

 +82-2-6949-5350   
 [email protected]

© 2023 요즈마 그룹 코리아.

  • Korean
  • About
    • Chairman
    • Overview
    • People
      • Team
      • Advisors & Partners
  • Business
  • YIC
  • Portfolio
  • Newsroom
  • Contact
Yozma Group Korea Co., Ltd

Seoul Address
5F, SB Tower, 318 Dosan-daero, Gangnam-Gu, Seoul 06054, Republic of Korea


 +82-2-6949-5350   
 [email protected]